Purpose: The objective of this study was to assess the usefulness of low-dose intratympanic gentamicin administration in patients with Meniere's disease (MD). Materials and Methods: We carried out a retrospective review of the charts of 55 patients with definite MD in accordance with the AAO-HNS (American Academy of Otolaryngology-Head and Neck Surgery) Diagnostic Scale who were treated at Gruppo Otologico (Piacenza, Rome, Italy). The treatment protocol consisted of 3 intratympanic injections of gentamicin at a 12-hour interval between each administration. Results: Results were resumed in accordance with AAO-HNS criteria and showed complete control of vertigo spells in 60% (class A), good control in 16% (class B), moderate control in 4% (class C), poor control in 16% (class D), and no control in 4% (class E) of the patients. Audiological assessment showed unchanged thresholds in 61%, improvement in 22%, and worsening in 17% of the cases. Conclusion: Administration of gentamicin is a good alternative to medical and surgical procedures in the treatment of intractable MD. One-day treatment allows for adequate control of vertigo attacks without compromising hearing and quality of life and with reduced costs. © 2007.

De Stefano A., Dispenza F., De Donato G., Caruso A., Taibah A., Sanna M. (2007). Intratympanic gentamicin: a 1-day protocol treatment for unilateral Meniere's disease. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 28(5), 289-293 [10.1016/j.amjoto.2006.09.009].

Intratympanic gentamicin: a 1-day protocol treatment for unilateral Meniere's disease

De Stefano A.
Primo
;
Dispenza F.
Secondo
;
2007-01-01

Abstract

Purpose: The objective of this study was to assess the usefulness of low-dose intratympanic gentamicin administration in patients with Meniere's disease (MD). Materials and Methods: We carried out a retrospective review of the charts of 55 patients with definite MD in accordance with the AAO-HNS (American Academy of Otolaryngology-Head and Neck Surgery) Diagnostic Scale who were treated at Gruppo Otologico (Piacenza, Rome, Italy). The treatment protocol consisted of 3 intratympanic injections of gentamicin at a 12-hour interval between each administration. Results: Results were resumed in accordance with AAO-HNS criteria and showed complete control of vertigo spells in 60% (class A), good control in 16% (class B), moderate control in 4% (class C), poor control in 16% (class D), and no control in 4% (class E) of the patients. Audiological assessment showed unchanged thresholds in 61%, improvement in 22%, and worsening in 17% of the cases. Conclusion: Administration of gentamicin is a good alternative to medical and surgical procedures in the treatment of intractable MD. One-day treatment allows for adequate control of vertigo attacks without compromising hearing and quality of life and with reduced costs. © 2007.
2007
De Stefano A., Dispenza F., De Donato G., Caruso A., Taibah A., Sanna M. (2007). Intratympanic gentamicin: a 1-day protocol treatment for unilateral Meniere's disease. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 28(5), 289-293 [10.1016/j.amjoto.2006.09.009].
File in questo prodotto:
File Dimensione Formato  
6. Intratympanic gentamicin.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 110.72 kB
Formato Adobe PDF
110.72 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/582314
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 14
social impact